{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:18:50Z","timestamp":1783948730488,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"DOI":"10.1186\/s13756-026-01759-y","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:06:07Z","timestamp":1779203167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Re-evaluating microbiological testing and isolation measures for suspected MRSA carriers: insights from a retrospective study in a Dutch tertiary care center"],"prefix":"10.1186","volume":"15","author":[{"given":"Sofie C. M.","family":"Tops","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Meddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corianne","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan D.","family":"Pas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette","family":"Rahamat-Langendoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edm\u00e9e C.","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Tostmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"8","key":"1759_CR1","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","volume":"28","author":"AD Bai","year":"2022","unstructured":"Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A, et al. Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(8):1076\u201384.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1759_CR2","doi-asserted-by":"publisher","first-page":"e0148175","DOI":"10.1371\/journal.pone.0148175","volume":"11","author":"D Souverein","year":"2016","unstructured":"Souverein D, Houtman P, Euser SM, Herpers BL, Kluytmans J, Den Boer JW. Costs and benefits associated with the MRSA Search and Destroy policy in a hospital in the Region Kennemerland, The Netherlands. PLoS ONE. 2016;11(2):e0148175.","journal-title":"PLoS ONE"},{"issue":"2","key":"1759_CR3","first-page":"131","volume":"32","author":"S Adeiza","year":"2024","unstructured":"Adeiza S, Aminul I. Meta-meta-analysis of the mortality risk associated with MRSA compared to MSSA bacteraemia. Infez Med. 2024;32(2):131\u20137.","journal-title":"Infez Med"},{"key":"1759_CR4","unstructured":"Stichting Werkgroep Antibioticabeleid (SWAB), Centrum Infectieziektenbestrijding (CIb) van het Rijksinstituut voor Volksgezondheid en Milieu (RIVM). NethMap\/MARAN 2024: gebruik van antimicrobi\u00eble middelen en resistentieontwikkeling bij bacteri\u00ebn van medisch belang in Nederland. Bilthoven: RIVM. 2024. Rapportnummer 2024\u2009\u2013\u20090117. Available from: https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2024-0117.pdf"},{"key":"1759_CR5","volume-title":"Antimicrobial resistance \u2013 Annual epidemiological report for 2023 \u2013 EARS-Net","author":"ECDC","year":"2023","unstructured":"ECDC. Antimicrobial resistance: Annual epidemiological report for 2023\u2014EARS-Net. Stockholm: European Centre for Disease Prevention and Control; 2023."},{"key":"1759_CR6","unstructured":"World Health Organization. Global antibiotic resistance surveillance report 2025. Geneva: World Health Organization. 2025. ISBN: 9789240116337. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240116337"},{"issue":"11","key":"1759_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s10096-002-0811-4","volume":"21","author":"M Vriens","year":"2002","unstructured":"Vriens M, Blok H, Fluit A, Troelstra A, Van Der Werken C, Verhoef J. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur J Clin Microbiol Infect Dis. 2002;21(11):782.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"14","key":"1759_CR8","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1001\/jama.290.14.1899","volume":"290","author":"HT Stelfox","year":"2003","unstructured":"Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA. 2003;290(14):1899\u2013905.","journal-title":"JAMA"},{"key":"1759_CR9","unstructured":"Radboudumc. Jaarverslagen [Internet]. Nijmegen: Radboudumc; c2025 [cited 2025 Sep 4]. Available from: https:\/\/www.radboudumc.nl\/over-het-radboudumc\/organisatie\/publicaties-en-verantwoording\/jaarverslagen"},{"issue":"1","key":"1759_CR10","doi-asserted-by":"publisher","first-page":"17998","DOI":"10.1038\/s41598-020-75094-6","volume":"10","author":"G Raschpichler","year":"2020","unstructured":"Raschpichler G, Raupach-Rosin H, Akmatov MK, Castell S, Rubsamen N, Feier B, et al. Development and external validation of a clinical prediction model for MRSA carriage at hospital admission in Southeast Lower Saxony, Germany. Sci Rep. 2020;10(1):17998.","journal-title":"Sci Rep"},{"issue":"11","key":"1759_CR11","doi-asserted-by":"publisher","first-page":"e0188502","DOI":"10.1371\/journal.pone.0188502","volume":"12","author":"WSN Lekkerkerk","year":"2017","unstructured":"Lekkerkerk WSN, Haenen A, van der Sande MAB, Leenstra T, de Greeff S, Timen A, et al. Newly identified risk factors for MRSA carriage in The Netherlands. PLoS ONE. 2017;12(11):e0188502.","journal-title":"PLoS ONE"},{"key":"1759_CR12","unstructured":"Holwerda MM, Coenen C, van Weerdenburg O, Bowles I, Tostmann A. MRSA and MDRO screening positivity rates among high-risk patients in a Dutch academic hospital: evaluating the \u2018screening-at-the-gate\u2019 policy. ePoster presented at: ECCMID. 2021; 2021 9\u201312; Vienna, Austria. Session: 8e Hospital epidemiology, transmission, surveillance & screening (incl environment). Eposter."}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-026-01759-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-026-01759-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-026-01759-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:02:02Z","timestamp":1783947722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13756-026-01759-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1759"],"URL":"https:\/\/doi.org\/10.1186\/s13756-026-01759-y","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The IPC unit, Dept. Medical Microbiology has a general approval from the institutional Medical Ethics Review Committee (CMO) to conduct medical-scientific research on laboratory and patient data for policy evaluation purposes (CMO number 2015\u2009\u2212\u20091764).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}